In This Article:
Participants
Vincent Kondaveeti; Head of Investor Relation; Exela Technologies Inc
Matthew Brown; Interim Chief Financial Officer; Exela Technologies Inc
Presentation
Operator
Good afternoon, and welcome to the Exela Technologies first quarter 2024 financial results conference call. (operator Instructions) Please note, this event is being recorded. I would now like to turn the conference over to Vincent Kondaveeti, Head of Investor Relations. Please go ahead.
Vincent Kondaveeti
Thank you, Gary, and good afternoon. Welcome to our earnings call to discuss our first quarter results for the period ended March 31, 2024. Our presentations was uploaded to the IR section of our website. Matt Brown, our Interim CFO, will be hosting the call. Par unfortunately had some travel delays and can't dial in.
Today's agenda will largely follow our prior calls with management commentary, followed by Q&A. Some of the matters we will discuss in today's call are forward-looking and involve a number of risks, uncertainties and other factors that could actual results to differ materially from those in such forward-looking statements. Such risks and uncertainties are set forth in our presentation.
So with that, I'll turn over the call to Matt.
Matthew Brown
Good afternoon, everyone. Let's move to slide 8, financial highlights. We reported first quarter revenues of $258.8 million, down 5.4% year-over-year or 4.3% pro forma for the sale of the high-speed scanner business. Information and transaction processing solutions declined by 9% year-over-year, offset by growth in our health care solutions and legal and loss prevention services segments by approximately 3% and 6%, respectively.
Sequentially, IPTS was down 3% in Q1 due to the loss of a $27 million low margin contract renewal. Healthcare solutions was up 4% with continued volume increases and LLPS was down 12% due to project fluctuations.
Q1 gross margins were 22%, up 107 basis points year-over-year, and we continue to focus on driving automation and operational leverage. Healthcare and LLPS margins are up 296 basis points and 242 basis points year-over-year and ITPS margin was relatively flat given the contract exit.
SG&A is down 43 basis points year-over-year, primarily driven by reductions in legal and professional fees. We're making investments in new business divisions such as Reaktr.ai and shifting from CapEx to OpEx as we move our data center infrastructure to the cloud.
Since year end, we've consolidated over 100,000 square feet of real estate and have approximately 340,000 square feet of additional consolidations in process. We have made good progress and savings initiatives but still have significant opportunity for margin improvement throughout the rest of the year.
We had a net loss of $25.6 million, an improvement of $20 million year-over-year, mainly driven by lower interest and debt expense. Adjusted EBITDA was $12.9 million, and we expect to continue driving margin improvement throughout the year.
On page 10, we have both our financial highlights and lowlights. We achieved gross margin improvement despite a number of headwinds. On the balance sheet, current liabilities are down 23% and our interest expense is down 52% year-over-year. While we had a large customer exit with a $27 million contract falling off starting in January, we are seeing revenue stabilization and growth opportunities with both the 96% renewal rate in Q1 along with 85 new logo wins.
We are focused on expanding liquidity and managing rising taxes as our NOLs are reduced. Unrestricted cash in Q1 was approximately $10 million after we made our interest payment, while cash flow from operations continues to improve and we're progressing various financing initiatives in parallel.
In 2024, our focus remains on driving revenue stabilization, margin improvement and strategic growth initiatives. We are optimistic about achieving many of our objectives this year as we continue to improve profitability and liquidity. Thank you. We will now open the line up for questions.